Moreover, we showed that in vivo transplantation of BM-MNCs from IA-HSC+ MDS in contrast to IA-HSC− patients resulted in human xenotransplants with high CD34+ counts and immunophenotypic aberrant CD34+CD38− cells. The gene discussed is CD34; the disease is myelodysplastic syndrome.